Pasi Antero Jänne, MD, PhD, is an Associate Professor of Medicine at Harvard Medical School and a clinician at Dana-Farber Cancer Institute Lowe Center for Thoracic Oncology. Dr. Jänne is a leading researcher in medical oncology and lung cancer and is Co-Leader of the Lung Cancer Program at Dana-Farber Harvard Cancer Center. His research includes the study of epidermal growth factor receptor mutations in non-small cell lung cancer and their impact on the efficacy of EGFR-targeted therapeutic agents, as well as mechanisms of sensitivity and resistance targeted cancer therapies.
Achievements
Professor of Medicine, Harvard Medical School and Brigham & Women’s Hospital; Director of Dana Farber Cancer Institute Lowe Center for Thoracic Oncology, and Scientific Director of the Belfer Center for Applied Cancer Science